{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:01:58Z","timestamp":1754092918191,"version":"3.41.2"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jid.2024.04.014","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T13:57:02Z","timestamp":1718719022000},"page":"1689-1695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Setting the Stage for Standardized Reporting of Clinical and Demographic Information in Laboratory-Based Studies of Hidradenitis Suppurativa"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5963-4938","authenticated-orcid":false,"given":"Stephanie L.","family":"Schell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6375-8706","authenticated-orcid":false,"given":"Amanda M.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2024.04.014_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48226-w","article-title":"Specimen collection for translational studies in hidradenitis suppurativa","volume":"9","author":"Byrd","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2024.04.014_bib2","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/jid.2012.472","article-title":"Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study","volume":"133","author":"Canoui-Poitrine","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/bjd\/ljad273","article-title":"Aberrant expression of interleukin-17A in mast cells contributes to the pathogenesis of hidradenitis suppurativa","volume":"189","author":"Chu","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib4","article-title":"Overview and comparison of the clinical scores in hidradenitis suppurativa: a real-life clinical data","volume":"10","author":"Daoud","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2024.04.014_bib5","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1111\/jdv.17023","article-title":"European registry for hidradenitis suppurativa: state of play","volume":"35","author":"Daxhelet","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.04.014_bib6","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/jdv.13267","article-title":"Establishment of a European Registry for hidradenitis suppurativa\/acne inversa by using an open source software","volume":"30","author":"Daxhelet","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.04.014_bib7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3390\/biom12101371","article-title":"Transcriptome meta-analysis confirms the hidradenitis suppurativa pathogenic triad: upregulated inflammation, altered epithelial organization, and dysregulated metabolic signaling","volume":"12","author":"de Oliveira","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jid.2024.04.014_bib8","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.jid.2019.04.008","article-title":"Major differences in expression of inflammatory pathways in skin from different body sites of healthy individuals","volume":"139","author":"Del Duca","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib9","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.12688\/f1000research.17267.1","article-title":"A\u00a0systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa","volume":"7","author":"Frew","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.jid.2024.04.014_bib10","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/bjd.18309","article-title":"Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: proposed recommendations for clinical trials and translational research studies","volume":"181","author":"Frew","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib11","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/exd.13978","article-title":"Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa\/ acne inversa","volume":"28","author":"Frew","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States","volume":"153","author":"Garg","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib13","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1171700","article-title":"Topographical and temporal diversity of the human skin microbiome","volume":"324","author":"Grice","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jid.2024.04.014_bib14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/jamadermatol.2021.2865","article-title":"Differences between children and adults with hidradenitis suppurativa","volume":"157","author":"Hallock","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib15","article-title":"Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus","volume":"39","author":"Hurley","year":"1989","journal-title":"Surg Approach"},{"issue":"Suppl. 1","key":"10.1016\/j.jid.2024.04.014_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/exd.14610","article-title":"Registries, multicentre and genome-wide association studies in hidradenitis suppurativa","volume":"31","author":"Jemec","year":"2022","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5021\/ad.23.090","article-title":"Review of scoring systems for hidradenitis suppurativa","volume":"36","author":"Kim","year":"2024","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2024.04.014_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000508787","article-title":"Delayed diagnosis of hidradenitis suppurativa and its effect on patients and healthcare system","volume":"236","author":"Kokolakis","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2024.04.014_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bjd\/ljad345","article-title":"Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape","volume":"190","author":"Krueger","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.3643","article-title":"A\u00a0gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases","volume":"18","author":"Liang","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2024.04.014_bib22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/jdv.16183","article-title":"Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study","volume":"34","author":"Martorell","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.04.014_bib23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/ced.12655","article-title":"Atypical hidradenitis suppurativa","volume":"40","author":"Naasan","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jdv.16677","article-title":"Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life","volume":"35","author":"Nguyen","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.04.014_bib25","first-page":"7240","article-title":"Current medical and surgical treatment of hidradenitis suppurativa-a comprehensive review","volume":"11","author":"Ocker","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jid.2024.04.014_bib26","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1038\/jid.2014.220","article-title":"Ethnicity and hidradenitis suppurativa","volume":"134","author":"Reeder","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2024.04.014_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/bjd\/ljac096","article-title":"Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies","volume":"188","author":"Schell","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib29","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/exd.14398","article-title":"Yin and Yang: A disrupted skin microbiome and an aberrant host immune response in hidradenitis suppurativa","volume":"30","author":"Schell","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jamadermatol.2023.2217","article-title":"Genetic variants associated with hidradenitis suppurativa","volume":"159","author":"Sun","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jdv.14599","article-title":"Low and high body mass index in hidradenitis suppurativa patients-different subtypes?","volume":"32","author":"Theut Riis","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.04.014_bib32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.16672","article-title":"A\u00a0core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process","volume":"179","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00403-020-02149-z","article-title":"Sub-classification of Hidradenitis suppurativa: a cross-sectional study","volume":"314","author":"Thorlacius","year":"2022","journal-title":"Arch Dermatol Res"},{"issue":"Suppl. 1","key":"10.1016\/j.jid.2024.04.014_bib34","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jaad.2015.07.047","article-title":"New insights into the diagnosis of hidradenitis suppurativa: clinical presentations and phenotypes","volume":"73","author":"van der Zee","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13059-015-0644-y","article-title":"Age and sun exposure-related widespread genomic blocks of hypomethylation in nonmalignant skin","volume":"16","author":"Vandiver","year":"2015","journal-title":"Genome Biol"},{"key":"10.1016\/j.jid.2024.04.014_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","article-title":"Incidence of hidradenitis suppurativa and associated factors: a population-based study\u00a0of Olmsted County, Minnesota","volume":"133","author":"Vazquez","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib37","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjd.12787","article-title":"The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa","volume":"170","author":"Vinding","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/bjd\/ljad454","article-title":"Global consensus process to establish a core data set for hidradenitis suppurativa registries","volume":"190","author":"Wainman","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib39","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/bjd.19556","article-title":"Aetiology and pathogenesis of hidradenitis suppurativa","volume":"183","author":"Wolk","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.04.014_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/pharmaceutics14010044","article-title":"Hidradenitis suppurativa and comorbid disorder biomarkers, druggable genes, new drugs and drug repurposing-a molecular meta-analysis","volume":"14","author":"Zouboulis","year":"2021","journal-title":"Pharmaceutics"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X24003737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X24003737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:55:02Z","timestamp":1754009702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X24003737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0022202X24003737"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2024.04.014","relation":{},"ISSN":["0022-202X"],"issn-type":[{"type":"print","value":"0022-202X"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Setting the Stage for Standardized Reporting of Clinical and Demographic Information in Laboratory-Based Studies of Hidradenitis Suppurativa","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2024.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}